Raclopride: a selective dopamine D2 antagonist without extrapyramidal adverse effects

InPharma ◽  
1989 ◽  
Vol 695 (1) ◽  
pp. 5-5
Keyword(s):  
Adverse Effects ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine

The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial

1991 ◽  
Vol 4 (3) ◽  
pp. 311-312
Author(s):  
A.G. Awad ◽  
Y.D. Lapierre ◽  
N.P.V. Nair ◽  
P. Beaudry ◽  
B. Saxena ◽  
...  
Keyword(s):  
Multicenter Trial ◽  
Acute Schizophrenia ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine

Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studies

1990 ◽  
Vol 3 (1) ◽  
pp. 43 ◽  
Author(s):  
A.G. Awad ◽  
R. Ancill ◽  
A.G. Awad ◽  
D. Bakish ◽  
P. Beaudry ◽  
...  
Keyword(s):  
Acute Schizophrenia ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist ◽  
Selective Dopamine

Object recognition impairment and rescue by a dopamine D2 antagonist in hyperdopaminergic mice

2016 ◽  
Vol 308 ◽  
pp. 211-216 ◽  
Author(s):  
Arthur S.C. França ◽  
Larissa Muratori ◽  
George Carlos Nascimento ◽  
Catia Mendes Pereira ◽  
Sidarta Ribeiro ◽  
...  
Keyword(s):  
Object Recognition ◽  
Dopamine D2 ◽  
Dopamine D2 Antagonist ◽  
D2 Antagonist
Sign in / Sign up

Export Citation Format

Share Document